Geron | GERN - Net Income


Geron reported $1.35M in Net Income for its fiscal quarter ending in September of 2026.





Net Income Change Date
Amgen USD 3.86B 1.49B Sep/2026
Bio Techne USD 28.29M 26.33M Sep/2026
Cassava Sciences USD -8.6M 1.73M Jun/2026
Cytokinetics USD -190.07M 8.69M Sep/2026
Exelixis USD 218.1M 6.04M Sep/2026
Genmab DKK 303M 250M Jun/2026
Geron USD 1.35M 18.03M Sep/2026
Gilead Sciences USD -10.5B 12.52B Jun/2026
Incyte USD -784.8M 1.37B Sep/2026
MacroGenics USD 19.52M 56.29M Jun/2026
Novartis USD 1.2B 2.06B Sep/2026
Novavax USD 17.53M 219.91M Dec/2025